For how we live.
A pooled study of 1.44 million adults links activity to lower risk of 13 cancers — but not all, and not melanoma. A 2025 randomised trial now shows exercise after colon cancer improves survival.
Registries show a real but narrow signal: a few cancers, led by prostate and thyroid, run high in 9/11 responders, while overall cancer incidence sits at or below the rate expected.
Pooled diagnostic accuracy is high in specialist settings, but performance falls on Fitzpatrick IV–VI skin and on smartphone images, and most studies never report skin tone at all.
A meta-analysis of 155 studies puts photo-based skin diagnosis close to a face-to-face visit for common conditions. For skin cancer the agreement is lower, and hinges on dermoscopy.
Most skin cancers rarely kill; melanoma, about 1 percent of them, causes most of the deaths. There is no proven benefit from routine whole-body screening — which puts the focus on changing moles.
Moderna and Merck's personalized vaccine slowed melanoma's return when added to Keytruda. It is the first mRNA cancer vaccine to succeed at scale — and the first real test of a decade-old idea.
SPF measures how much ultraviolet exposure it takes to burn, not how long you can stay outside. The randomised cancer-prevention evidence rests largely on 1,621 adults followed for more than a decade.
The MITRIC basket trial gave 12 patients with immunotherapy-resistant cancer stool transplants from patients who had responded. It was safe but produced no objective tumour responses.
The CHMP's June meeting recommended pulling avacopan from the EU market on data-integrity grounds, refused three cell and biological therapies, and reversed itself on a Rett syndrome drug it had earlier rejected.
A linked-registry cohort of New South Wales residents from 2001 to 2018 finds cancer risk in people with intellectual disability inverts with age — higher when young, lower after 50.
Integrated risk scores combine polygenic data with conventional risk factors. A readiness review lists what would have to exist first — and separately, 36% of older Australians had no skin check at all last year.
Fifty-five per cent of surveyed cricketers over 70 reported a basal cell carcinoma. A 29% response rate and self-reported diagnoses mean the number cannot be read as a rate — which is the finding.